低剂量肾上腺素联合氨甲环酸减少全膝关节置换术后早期失血与炎症反应:一项随机对照试验
该随机安慰剂对照试验纳入179例初次全膝关节置换患者,比较静脉低剂量肾上腺素联合氨甲环酸、局部稀释肾上腺素联合氨甲环酸与单用氨甲环酸三种方案。结果显示静脉联合组术后第1天和第3天计算总失血量均显著低于另两组,且未明显诱发高凝状态,输血值显著降低,血栓栓塞并发症、伤口评分、活动度及HSS评分三组无显著差异。
要点
- 静脉低剂量肾上腺素联合氨甲环酸组术后第1天失血量348.1±158.2 mL,显著低于局部联合组420.5±188.4 mL和单用氨甲环酸组520.4±228.4 mL(p<0.05)。
- 静脉低剂量肾上腺素联合氨甲环酸组术后第3天失血量458.0±183.4 mL,显著低于局部联合组531.1±231.4 mL和单用氨甲环酸组633.7±237.3 mL(p<0.05)。
- 三组血栓栓塞并发症发生率、伤口评分、活动度及HSS评分无显著差异(p>0.05),静脉联合组输血值显著降低(p<0.05)。
核心结论
- 与单用氨甲环酸相比,低剂量肾上腺素联合氨甲环酸在减少全膝关节置换围手术期失血和炎症反应方面效果更明显,且未明显增加血栓栓塞及其他并发症发生率。
研究设计与样本
- 随机安慰剂对照试验,纳入179例连续接受初次全膝关节置换的患者,随机分为静脉低剂量肾上腺素联合氨甲环酸组、局部稀释肾上腺素联合氨甲环酸组和单用氨甲环酸组。
主要发现
- 静脉联合组术后第1天计算总失血量为348.1±158.2 mL,显著低于局部联合组的420.5±188.4 mL和单用氨甲环酸组的520.4±228.4 mL(p<0.05)。
- 静脉联合组术后第3天计算总失血量为458.0±183.4 mL,显著低于局部联合组的531.1±231.4 mL和单用氨甲环酸组的633.7±237.3 mL(p<0.05)。
- 静脉低剂量肾上腺素在全膝关节置换中表现出净抗炎活性,且未诱发明显的高凝状态。
- 静脉联合组输血值显著降低(p<0.05),三组血栓栓塞并发症发生率、伤口评分、活动度及HSS评分无显著差异(p>0.05)。
临床怎么用
- 作者结论认为,低剂量肾上腺素联合氨甲环酸较单用氨甲环酸在减少围手术期失血和炎症反应方面效果更明显,且未明显增加血栓栓塞及其他并发症发生率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The reductions of perioperative blood loss and inflammatory response are important in total knee arthroplasty. Tranexamic acid reduced blood loss and the inflammatory response in several studies. However, the effect of epinephrine administration plus tranexamic acid has not been intensively investigated, to our knowledge. In this study, we evaluated whether the combined administration of low-dose epinephrine plus tranexamic acid reduced perioperative blood loss or inflammatory response further compared with tranexamic acid alone. METHODS: This randomized placebo-controlled trial consisted of 179 consecutive patients who underwent primary total knee arthroplasty. Patients were randomized into 3 interventions: Group IV received intravenous low-dose epinephrine plus tranexamic acid, Group TP received topical diluted epinephrine plus tranexamic acid, and Group CT received tranexamic acid alone. The primary outcome was perioperative blood loss on postoperative day 1. Secondary outcomes included perioperative blood loss on postoperative day 3, coagulation and fibrinolysis parameters (measured by thromboelastography), inflammatory cytokine levels, transfusion values (rate and volume), thromboembolic complications, length of hospital stay, wound score, range of motion, and Hospital for Special Surgery (HSS) score. RESULTS: The mean calculated total blood loss (and standard deviation) in Group IV was 348.1 ± 158.2 mL on postoperative day 1 and 458.0 ± 183.4 mL on postoperative day 3, which were significantly reduced (p < 0.05) compared with Group TP at 420.5 ± 188.4 mL on postoperative day 1 and 531.1 ± 231.4 mL on postoperative day 3 and Group CT at 520.4 ± 228.4 mL on postoperative day 1 and 633.7 ± 237.3 mL on postoperative day 3. Intravenous low-dose epinephrine exhibited a net anti-inflammatory activity in total knee arthroplasty and did not induce an obvious hypercoagulable status. Transfusion values were significantly reduced (p < 0.05) in Group IV, but no significant differences were observed in the incidence of thromboembolic complications, wound score, range of motion, and HSS score among the 3 groups (p > 0.05). CONCLUSIONS: The combined administration of low-dose epinephrine and tranexamic acid demonstrated an increased effect in reducing perioperative blood loss and the inflammatory response compared with tranexamic acid alone, with no apparent increased incidence of thromboembolic and other complications. LEVEL OF EVIDENCE: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
引用
- Zeng WN, Liu JL, Wang FY, et al. Low-Dose Epinephrine Plus Tranexamic Acid Reduces Early Postoperative Blood Loss and Inflammatory Response: A Randomized Controlled Trial. J Bone Joint Surg Am. 2018. PMID: 29462033. doi:10.2106/JBJS.16.01585
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。